Interferon beta 1A 44micrograms/0.5ml

This tender concerns the procurement of Interferon beta 1A, with a specific dosage of 44 micrograms per 0.5ml. The required quantity ranges from a minimum of 128 cartridges to a maximum of 1,536 cartridges. This medication is typically used for treating conditions such as multiple sclerosis. The tender specifies the exact pharmaceutical product and the volume required, indicating a need for a consistent supply over a period. Potential bidders are expected to provide offers for the specified Interferon beta 1A, meeting the quality and quantity requirements. This procurement is crucial for ensuring the availability of essential medical treatment for patients.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Romania, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.